Selventa, which evolved from Genstruct, Inc. announced that it has changed its name and launched a re-branded Web site as part of an initiative to provide innovative solutions for its client partners. The company’s core strengths embrace a customer-focused approach that leverages existing patient data and innovative analytics to help pharmaceutical and biotechnology partners accelerate development and clarify decisions on therapeutics and diagnostics, according to a company statement.
“Selventa‘s new business strategy enables us to partner with clients at a deeper level to help them solve project portfolio development challenges and make a bigger impact on drug discovery,” said David de Graaf, PhD, chief scientific officer of Selventa. “The new company name, which is derived from a word meaning clarity, reflects our new focused approach.”
In addition to the company’s name change, Selventa has embarked upon an entire corporate re-branding effort as demonstrated by its new corporate Web site. The updated content is more emblematic of the company’s commitment to consulting services, licensed software products and strategic partnerships that help clients find optimal treatments for the right patients. Selventa works with a variety of clients in the pharmaceutical, biotechnology and life science industries as well as academic institutions.
“As a personalized healthcare organization, we are addressing global industry challenges and critical needs in the research and development continuum,” said Louis Latino, Selventa’s executive vice president of sales and marketing. “The company based these changes on client input and will continue to integrate new ideas with existing programs for future initiatives.”
Date: November 30, 2010